Bioxytran Inc (BIXT)

$0.09 -0.01 (-6.42%)
Market Cap 7.65M
Revenue (ttm) 0.00
Net Income (ttm) -2.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.02
Volume 37,300
Avg Vol 132,824
Day's Range N/A - N/A
Shares Out 88.99M
Stochastic %K 20%
Beta 1.55
Analysts Strong Buy
Price Target N/A

Company Profile

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLec...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 454 1199
Address:
75 2nd Avenue, Ste 605, Needham, United States
History101
History101 Jul. 23 at 11:48 PM
$BIXT "The other three priorities are unchanged from the June notice, but the FDA has provided new examples. The agency named “a universal flu vaccine that could provide broad protection against multiple strains of influenza, including those with pandemic potential,” as an example of a product that could address a U.S. public health crisis."
0 · Reply
History101
History101 Jul. 23 at 8:05 PM
$BIXT BIXT management needs to get on this asap: "FDA officials plan to pick up to five companies to participate in the pilot in the first year of the program. To accelerate reviews, the FDA will convene a senior, multidisciplinary review committee led by its Office of the Chief Medical and Scientific Officer. The FDA contrasted the model to its standard approach of sending applications to numerous offices staffed by reviewers who are “juggling competing priorities.”" https://www.fiercebiotech.com/biotech/fda-opens-national-priority-fast-track-offering-2-month-reviews-onshoring-and-affordability
0 · Reply
History101
History101 Jul. 22 at 8:16 PM
$BIXT 248 watching 7/22/2025
0 · Reply
History101
History101 Jul. 22 at 8:02 PM
$BIXT lovin my 090 cost basis...GLTALs!!
0 · Reply
History101
History101 Jul. 18 at 5:57 PM
$BIXT able to buy a bunch below 9.1 cents today, awesome!! GLTALs!!
0 · Reply
Ashakom
Ashakom Jun. 30 at 7:09 PM
$BIXT SELL TO ME
0 · Reply
Investandcashed
Investandcashed Jun. 20 at 5:18 PM
$BIXT Why should I invest into this stock? Can someone give me some good points?
1 · Reply
Selett
Selett Jun. 19 at 2:27 PM
$BIXT - when / how are they getting funding??
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 18 at 3:19 PM
$BIXT News is out. https://finance.yahoo.com/news/bioxytran-secures-source-gmp-quality-145000571.html
1 · Reply
DiamondCapital
DiamondCapital Jun. 17 at 1:25 PM
BFC Virtual Conference is live!! SESSION C - 9AM EST Watch here: https://x.com/stockpicksnyc/status/1934964263640269019?s=46 Companies presenting: $EHVVF Joey Ricard of Ehaveinc $ICTY Management of EyeCity $BIXT Mike Sheikh of BioxytranInc Also being broadcasted on YouTube here: https://www.youtube.com/watch?v=tHYbSbbGC1I
0 · Reply
Latest News on BIXT
No data available.
History101
History101 Jul. 23 at 11:48 PM
$BIXT "The other three priorities are unchanged from the June notice, but the FDA has provided new examples. The agency named “a universal flu vaccine that could provide broad protection against multiple strains of influenza, including those with pandemic potential,” as an example of a product that could address a U.S. public health crisis."
0 · Reply
History101
History101 Jul. 23 at 8:05 PM
$BIXT BIXT management needs to get on this asap: "FDA officials plan to pick up to five companies to participate in the pilot in the first year of the program. To accelerate reviews, the FDA will convene a senior, multidisciplinary review committee led by its Office of the Chief Medical and Scientific Officer. The FDA contrasted the model to its standard approach of sending applications to numerous offices staffed by reviewers who are “juggling competing priorities.”" https://www.fiercebiotech.com/biotech/fda-opens-national-priority-fast-track-offering-2-month-reviews-onshoring-and-affordability
0 · Reply
History101
History101 Jul. 22 at 8:16 PM
$BIXT 248 watching 7/22/2025
0 · Reply
History101
History101 Jul. 22 at 8:02 PM
$BIXT lovin my 090 cost basis...GLTALs!!
0 · Reply
History101
History101 Jul. 18 at 5:57 PM
$BIXT able to buy a bunch below 9.1 cents today, awesome!! GLTALs!!
0 · Reply
Ashakom
Ashakom Jun. 30 at 7:09 PM
$BIXT SELL TO ME
0 · Reply
Investandcashed
Investandcashed Jun. 20 at 5:18 PM
$BIXT Why should I invest into this stock? Can someone give me some good points?
1 · Reply
Selett
Selett Jun. 19 at 2:27 PM
$BIXT - when / how are they getting funding??
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 18 at 3:19 PM
$BIXT News is out. https://finance.yahoo.com/news/bioxytran-secures-source-gmp-quality-145000571.html
1 · Reply
DiamondCapital
DiamondCapital Jun. 17 at 1:25 PM
BFC Virtual Conference is live!! SESSION C - 9AM EST Watch here: https://x.com/stockpicksnyc/status/1934964263640269019?s=46 Companies presenting: $EHVVF Joey Ricard of Ehaveinc $ICTY Management of EyeCity $BIXT Mike Sheikh of BioxytranInc Also being broadcasted on YouTube here: https://www.youtube.com/watch?v=tHYbSbbGC1I
0 · Reply
i_like_bb_stock
i_like_bb_stock Jun. 3 at 1:18 PM
$BIXT news https://www.otcmarkets.com/stock/BIXT/news/Bioxytrans-Groundbreaking-Stroke--Alzheimers-Tech-Gains-Validation-That-Measures-Oxygenation-Uptake-During-Strokes?id=481714
0 · Reply
ydrum
ydrum Jun. 2 at 1:06 PM
$BIXT
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 2 at 12:18 AM
$BIXT OMG, this is huge, all in one full color, visual guide to everything BIXT https://cdn.prod.website-files.com/5cd9cf5f4183373f6b248799/64f77bdeed36fb8767af6f94_Bioxytran%20Long-COVID%20Presentation%20UPDATED.pdf
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 2 at 12:12 AM
$BIXT https://cdn.prod.website-files.com/5cd9cf5f4183373f6b248799/64f77bdeed36fb8767af6f94_Bioxytran%20Long-COVID%20Presentation%20UPDATED.pdf https://twitter.com/realsheepwolf/status/1928134241587494927
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 2 at 12:01 AM
$BIXT
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 2 at 12:00 AM
$BIXT https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176262472 Only one company left with the best, grandest, safest, most effect, patent protected, Nobel Prize worth solution left to ended diseases caused by #Viruses, that I know of. $BIXT's Prolectin-M nd Prolectin-I broad spectrum #antiviral, #Galectin-3 Inhibitor. This is huge news. #Moderna just lost $700 Million dollars in funding, and the #FDA finally did the right thing, and the door is now wide open for $BIXT. www.Bioxytran.com technology could make Moderna mRNA tech obsolete
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 1 at 11:51 PM
$BIXT
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 1 at 11:50 PM
$BIXT
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 1 at 11:44 PM
$BIXT
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 1 at 11:43 PM
$BIXT
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 1 at 11:42 PM
$BIXT
0 · Reply
BCE_TechMaster
BCE_TechMaster Jun. 1 at 11:42 PM
$BIXT
0 · Reply